- Blueprint Medicines (NASDAQ:BPMC): Q2 EPS of -$0.70 beats by $0.03.
- Revenue of $7.07M (+162.8% Y/Y) beats by $2.66M.
- Press Release
Blueprint Medicines beats by $0.03, beats on revenue
Recommended For You
More Trending News
About BPMC Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
BPMC | - | - |
Blueprint Medicines Corporation |